MétaCan
Menu
Back to cohort
Record W4399422624 · doi:10.1016/j.annonc.2024.06.001

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

2024· article· en· W4399422624 on OpenAlexfundno aff
Dave E. W. van der Kruijssen, Sjoerd G. Elias, Peter M. van de Ven, Karlijn L. van Rooijen, Jorine ‘t Lam-Boer, Linda Mol, Cornelis J.A. Punt, Dirkje W. Sommeijer, Pieter J. Tanis, Jørn Dalsgaard Nielsen, M.K. Yilmaz, J.M.G.H. van Riel, D.K. Wasowiz-Kemps, O. J. L. Loosveld, George P. van der Schelling, J.W.B. de Groot, Henderik L. van Westreenen, Henrik Jakobsen, Paul Hamberg, M. Verseveld, Claudia Jaensch, Gábor Liposits, Peter van Duijvendijk, Jamal Oulad Hadj, Joost A.B. van der Hoeven, Marija Trajkovic, Johannes H.W. de Wilt, M. Koopman, Jeroen Vincent, Johannes A. Wegdam, Brigitte C.M. Haberkorn, Erwin van der Harst, Mathijs P. Hendriks, Wilhelmina H. Schreurs, Huib A. Cense, Ron C. Rietbroek, Marie-José de Gier, Edwin A. van Breugel, Aad I. de Vos, Rebecca P. M. Brosens, Pascal G. Doornebosch, Felix E. de Jongh, Wouter J. Vles, Marien O. den Boer, Jeroen W. A. Leijtens, A. J. Gelderblom, Koen Peeters, Bart C. Kuenen, Bareld B. Pultrum, Joyce M. van Dodewaard-de Jong, Esther C. J. Consten, A.J. Yes van de Wouw, Joop Konsten, Ronald Hoekstra, Martijn F. Lutke Holzik, Allert H. Vos, M.J. van Hoogstraten, Nis H. Schlesinger, Geert-Jan Creemers, Ignace H. J. T. de Hingh, Monica L Kjaer, Lone N. Petersen, Michael Seiersen, Rahim Altaf, Hester van Cruijsen, Daniël A. Hess, Lobke L. van Leeuwen-Snoeks, Apollo Pronk, Coen I.M. Baeten, Wendy M. van der Deure, Koop Bosscha, Heidi Schut, Wouter K. G. Leclercq, Lieke H. J. Simkens, Koen Reijnders, Kees van Arkel, W.M.U. Helma van Grevenstein, Anthony W. H. van de Ven, Ronald J.C.L.M. Vuylsteke, Philomeen Kuijer, Sandra D. Bakker, Hauwy Goei, Helgi H. Helgason, Gijs J.D. van Acker, Mehmet Temizkan, Marc W. A. van Tilburg, Michael F. Gerhards, Emile D. Kerver, Elske C. Gootjes, Peter Nieboer, Wim Bleeker, Gitta Bleeker

Bibliographic record

VenueAnnals of Oncology · 2024
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsnot available
FundersKWF KankerbestrijdingRocheRoche Canada
KeywordsMedicineColorectal cancerDanishResectionOncologyCancerInternal medicineSurgery

Abstract

fetched live from OpenAlex

BACKGROUND: Upfront primary tumor resection (PTR) has been associated with longer overall survival (OS) in patients with synchronous unresectable metastatic colorectal cancer (mCRC) in retrospective analyses. The aim of the CAIRO4 study was to investigate whether the addition of upfront PTR to systemic therapy resulted in a survival benefit in patients with synchronous mCRC without severe symptoms of their primary tumor. PATIENTS AND METHODS: This randomized phase III trial was conducted in 45 hospitals in The Netherlands and Denmark. Eligibility criteria included previously untreated mCRC, unresectable metastases, and no severe symptoms of the primary tumor. Patients were randomized (1 : 1) to upfront PTR followed by systemic therapy or systemic therapy without upfront PTR. Systemic therapy consisted of first-line fluoropyrimidine-based chemotherapy with bevacizumab in both arms. Primary endpoint was OS in the intention-to-treat population. The study was registered at ClinicalTrials.gov, NCT01606098. RESULTS: Between August 2012 and February 2021, 206 patients were randomized. In the intention-to-treat analysis, 204 patients were included (n = 103 without upfront PTR, n = 101 with upfront PTR) of whom 116 were men (57%) with median age of 65 years (interquartile range 59-71 years). Median follow-up was 69.4 months. Median OS in the arm without upfront PTR was 18.3 months (95% confidence interval 16.0-22.2 months) compared with 20.1 months (95% confidence interval 17.0-25.1 months) in the upfront PTR arm (P = 0.32). The number of grade 3-4 events was 71 (72%) in the arm without upfront PTR and 61 (65%) in the upfront PTR arm (P = 0.33). Three deaths (3%) possibly related to treatment were reported in the arm without upfront PTR and four (4%) in the upfront PTR arm. CONCLUSIONS: Addition of upfront PTR to palliative systemic therapy in patients with synchronous mCRC without severe symptoms of the primary tumor does not result in a survival benefit. This practice should no longer be considered standard of care.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.348
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of OncologySame topicColorectal Cancer Treatments and StudiesFrench-language works237,207